Mathew R, Dhillon V, Shepherd P
Department of Rheumatology, Western General Hospital, Edinburgh, Scotland, UK.
Clin Rheumatol. 2009 Jul;28(7):865-6. doi: 10.1007/s10067-009-1165-4. Epub 2009 Mar 21.
Mastocytosis is a clonal disorder of the mast cell and its precursor cells, and is characterised by proliferation and accumulation of mast cells within various organs, most commonly the skin. Systemic mastocytosis is a rare but well-recognised cause of secondary osteoporosis, accounting for about 1.25% of cases. The pathophysiological mechanism is probably multifactorial, including increased osteoclastic activity, and a direct effect of mast cell mediators like histamine, heparin, tryptase and cytokines. Here, we report the case of a middle-aged male patient with osteoporotic vertebral fractures as a rare presenting manifestation of systemic mastocytosis. In summary, systemic mastocytosis, although rare, should be considered as a cause in patients with idiopathic osteoporosis.
肥大细胞增多症是一种肥大细胞及其前体细胞的克隆性疾病,其特征是肥大细胞在各个器官(最常见于皮肤)内增殖和积聚。系统性肥大细胞增多症是继发性骨质疏松症的一种罕见但已得到充分认识的病因,约占病例的1.25%。其病理生理机制可能是多因素的,包括破骨细胞活性增加,以及组胺、肝素、类胰蛋白酶和细胞因子等肥大细胞介质的直接作用。在此,我们报告一例中年男性患者,其骨质疏松性椎体骨折是系统性肥大细胞增多症的一种罕见表现形式。总之,系统性肥大细胞增多症虽然罕见,但在特发性骨质疏松症患者中应被视为一种病因。